Niall Moloney, Aonghus Shortt, Lisa Ruttledge, Peter Harte
Company Description
FoodMarble provide technology to help patients and consumers to measure their digestion. This is done using a tiny, app-connected breath test device. In 2021, they sold over $1.5m direct-to-consumer (2x year-on-year growth). In Feb 2022, they launched their 2nd generation consumer device, which has led to further strong growth and as of July, they have now launched their 2nd generation medical device into US healthcare. With FDA clearance and health insurer reimbursement in place, they are set for immediate growth. The data collected from over 30,000 devices and counting is enabling new AI-powered approaches to helping both consumers and patients to overcome common, chronic digestive conditions from the home, at scale.